Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hohlfeld

Showing results (71-80 of 206) with videos related to

Pageof 21
Sort By:
Immunology Letters|October 1, 1994
Constitutive and cytokine-induced production of interleukin-6 by human myoblastsE Bartoccioni, D Michaelis, R Hohlfeld
International Review of Neurobiology|January 1, 1990
Myasthenia gravis: prototype of the antireceptor autoimmune diseasesS Schönbeck, S Chrestel, R Hohlfeld
Neuroscience|October 14, 2008
Neuro-immune crosstalk in CNS diseasesM Kerschensteiner, E Meinl, R Hohlfeld
Der Internist|February 28, 2015
[Immunotherapies for multiple sclerosis : review and update]J Havla, T Kümpfel, R Hohlfeld
Drug Safety|December 12, 2001
Risk-benefit assessment of glatiramer acetate in multiple sclerosisT Ziemssen, O Neuhaus, R Hohlfeld
Der Nervenarzt|September 24, 2002
[Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis]T Kümpfel, N Heydari, R Hohlfeld
Pflugers Archiv : European Journal of Physiology|September 1, 1981
Prejunctional effects of anticholinesterase drugs at the endplate: mediated by presynaptic acetylcholine receptors or by postsynaptic potassium efflux?R Hohlfeld, R Sterz, K Peper
The American Journal of Pathology|October 1, 1993
Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubesD Michaelis, N Goebels, R Hohlfeld
Deutsche Medizinische Wochenschrift (1946)|December 24, 2005
[Monoclonal antibodies improve therapy of relapsing multiple sclerosis. Molecular basis and clinical results of anti-VLA4 (natalizumab) therapy]R Gold, H-P Hartung, R Hohlfeld
Journal of Neuroimmunology|February 1, 1989
Analysis of immunoglobulin and T cell receptor gene rearrangements in the thymus of myasthenia gravis patientsH Tesch, R Hohlfeld, K V Toyka
Pageof 21

Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
Immunology Letters|October 1, 1994
Constitutive and cytokine-induced production of interleukin-6 by human myoblastsE Bartoccioni, D Michaelis, R Hohlfeld
International Review of Neurobiology|January 1, 1990
Myasthenia gravis: prototype of the antireceptor autoimmune diseasesS Schönbeck, S Chrestel, R Hohlfeld
Neuroscience|October 14, 2008
Neuro-immune crosstalk in CNS diseasesM Kerschensteiner, E Meinl, R Hohlfeld
Der Internist|February 28, 2015
[Immunotherapies for multiple sclerosis : review and update]J Havla, T Kümpfel, R Hohlfeld
Drug Safety|December 12, 2001
Risk-benefit assessment of glatiramer acetate in multiple sclerosisT Ziemssen, O Neuhaus, R Hohlfeld
Der Nervenarzt|September 24, 2002
[Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis]T Kümpfel, N Heydari, R Hohlfeld
Pflugers Archiv : European Journal of Physiology|September 1, 1981
Prejunctional effects of anticholinesterase drugs at the endplate: mediated by presynaptic acetylcholine receptors or by postsynaptic potassium efflux?R Hohlfeld, R Sterz, K Peper
The American Journal of Pathology|October 1, 1993
Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubesD Michaelis, N Goebels, R Hohlfeld
Deutsche Medizinische Wochenschrift (1946)|December 24, 2005
[Monoclonal antibodies improve therapy of relapsing multiple sclerosis. Molecular basis and clinical results of anti-VLA4 (natalizumab) therapy]R Gold, H-P Hartung, R Hohlfeld
Journal of Neuroimmunology|February 1, 1989
Analysis of immunoglobulin and T cell receptor gene rearrangements in the thymus of myasthenia gravis patientsH Tesch, R Hohlfeld, K V Toyka
Pageof 21